These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11806989)

  • 41. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation.
    Talvensaari K; Clave E; Douay C; Rabian C; Garderet L; Busson M; Garnier F; Douek D; Gluckman E; Charron D; Toubert A
    Blood; 2002 Feb; 99(4):1458-64. PubMed ID: 11830500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune reconstitution after HSCT in SCID-a cohort of conditioned and unconditioned patients.
    Manor U; Lev A; Simon AJ; Hutt D; Toren A; Bielorai B; Goldberg L; Stauber T; Somech R
    Immunol Res; 2019 Jun; 67(2-3):166-175. PubMed ID: 31222511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Advances in newborn screening and immune system reconstitution of severe combined immunodeficiency].
    Huang S; Zhao Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 48(4):351-357. PubMed ID: 31901036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.
    Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Gaya A; Martino R; Sierra J; Montserrat E
    Exp Hematol; 2005 Oct; 33(10):1240-8. PubMed ID: 16219547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Applying T-cell receptor excision circles and immunoglobulin κ-deleting recombination excision circles to patients with primary immunodeficiency diseases.
    Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Jaing TH; Shih YF; Tseng TY; Lin YL
    Ann Med; 2014 Nov; 46(7):555-65. PubMed ID: 25109505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Late thymic deficiency after HLA-haploidentical hematopoietic stem cell transplantation for severe combined immunodeficiency.
    Ege MJ; Schuetz C; Jacobsen EM; Müller-Langer SM; Furlan I; Sirin M; Pannicke U; Schwarz K; Debatin KM; Hönig M; Schulz A; Friedrich W
    J Allergy Clin Immunol; 2019 Apr; 143(4):1623-1626.e13. PubMed ID: 30529243
    [No Abstract]   [Full Text] [Related]  

  • 47. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrathymic administration of hematopoietic progenitor cells enhances T cell reconstitution in ZAP-70 severe combined immunodeficiency.
    Adjali O; Vicente RR; Ferrand C; Jacquet C; Mongellaz C; Tiberghien P; Chebli K; Zimmermann VS; Taylor N
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13586-91. PubMed ID: 16174749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation.
    Labrosse R; Boufaied I; Bourdin B; Gona S; Randolph HE; Logan BR; Bourbonnais S; Berthe C; Chan W; Buckley RH; Parrott RE; Cuvelier GDE; Kapoor N; Chandra S; Dávila Saldaña BJ; Eissa H; Goldman FD; Heimall J; O'Reilly R; Chaudhury S; Kolb EA; Shenoy S; Griffith LM; Pulsipher M; Kohn DB; Notarangelo LD; Pai SY; Cowan MJ; Dvorak CC; Haddad É; Puck JM; Barreiro LB; Decaluwe H
    J Allergy Clin Immunol; 2023 Jan; 151(1):260-271. PubMed ID: 35987350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.
    Lewin SR; Heller G; Zhang L; Rodrigues E; Skulsky E; van den Brink MR; Small TN; Kernan NA; O'Reilly RJ; Ho DD; Young JW
    Blood; 2002 Sep; 100(6):2235-42. PubMed ID: 12200390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.
    Amatuni GS; Currier RJ; Church JA; Bishop T; Grimbacher E; Nguyen AA; Agarwal-Hashmi R; Aznar CP; Butte MJ; Cowan MJ; Dorsey MJ; Dvorak CC; Kapoor N; Kohn DB; Markert ML; Moore TB; Naides SJ; Sciortino S; Feuchtbaum L; Koupaei RA; Puck JM
    Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30683812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Severe combined immunodeficiency: From its discovery to the perspective].
    Kanegane H; Imai K; Morio T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):145-154. PubMed ID: 28747600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
    Storek J; Joseph A; Espino G; Dawson MA; Douek DC; Sullivan KM; Flowers ME; Martin P; Mathioudakis G; Nash RA; Storb R; Appelbaum FR; Maloney DG
    Blood; 2001 Dec; 98(13):3505-12. PubMed ID: 11739150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal bone marrow transplantation for severe combined immunodeficiency.
    Kane L; Gennery AR; Crooks BN; Flood TJ; Abinun M; Cant AJ
    Arch Dis Child Fetal Neonatal Ed; 2001 Sep; 85(2):F110-3. PubMed ID: 11517204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Neonatal screening of severe combined immunodeficiencies].
    Thomas C; Mirallié S; Pierres C; Dert C; Clément MC; Mahlaoui N; Durand-Zaleski I; Fischer A; Audrain M;
    Arch Pediatr; 2015 Jun; 22(6):646-52. PubMed ID: 25896629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes.
    Bayram O; Haskologlu S; Bayrakoğlu D; Bal SK; Islamoglu C; Cipe FE; Kendirli T; Kursun N; Guner SN; Yildiran A; Bozdogan G; Yuksek M; Reisli I; Dalva K; Aytekin C; Boztug K; Dogu F; Ikinciogullari A
    J Clin Immunol; 2021 Oct; 41(7):1563-1573. PubMed ID: 34114123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
    Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
    J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matched unrelated bone marrow transplantation for combined immunodeficiency.
    Dalal I; Reid B; Doyle J; Freedman M; Calderwood S; Saunders F; Roifman CM
    Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.
    Lev A; Simon AJ; Bareket M; Bielorai B; Hutt D; Amariglio N; Rechavi G; Somech R
    PLoS One; 2012; 7(1):e30494. PubMed ID: 22295088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.